
News from rarecancernews.com
Information about rarecancernews.com
Where is rarecancernews.com located?rarecancernews.com's WebsiteMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top rarecancernews.com News

Cancer · MadridReyobiq (Rhenium Re186 Obisbemeda), an experimental radiation therapy being developed by Plus Therapeutics, has been cleared by the U.S. Food and Drug Administration (FDA) to begin clinical trials that will test the treatment in children with certain aggressive gliomas. This decision follows positive results from the first part of a Phase 1/2a trial (NCT01906385), called ReSPECT-GBM, in adults with recurrent glioma. A $3 million grant from the U…See the Story
Reyobiq Trial for High-Grade Pediatric Glioma Approved by FDA
100% Left coverage: 1 sources

United States · United StatesWILMINGTON, DE — The U.S. Food and Drug Administration (FDA) has approved Monjuvi® (tafasitamab-cxix) in combination with rituximab and lenalidomide for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL). This marks a significant milestone in providing a chemotherapy-free treatment option for this challenging and recurrent type of cancer. The approval follows data from the Phase 3 inMIND trial, which demonstrate…See the Story
FDA Approves Monjuvi Combination Therapy for Follicular Lymphoma
100% Center coverage: 1 sources